Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct patterns of glia repair and remyelination in antibody‐mediated demyelination models of multiple sclerosis and neuromyelitis optica
Yiting Liu, Katherine S. Given, Gregory P. Owens, et al.
Glia (2018) Vol. 66, Iss. 12, pp. 2575-2588
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response
Kathryn Pellerin, Stephen Rubino, Jeremy C. Burns, et al.
Brain (2021) Vol. 144, Iss. 8, pp. 2361-2374
Open Access | Times Cited: 48
Experimental animal models of aquaporin‐4‐IgG‐seropositive neuromyelitis optica spectrum disorders: progress and shortcomings
Tianjiao Duan, A. S. Verkman
Brain Pathology (2019) Vol. 30, Iss. 1, pp. 13-25
Open Access | Times Cited: 42
The Role of Antibodies in the Pathogenesis of Multiple Sclerosis
Xiaoli Yu, Michael W. Graner, Peter G. E. Kennedy, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 35
Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1–anchored membrane domains
Gregory P. Owens, Timothy J. Fellin, Adeline Matschulat, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 19
Open Access | Times Cited: 12
Advances in maintenance therapies for neuromyelitis optica spectrum disorders: a new era of targeted drugs
Yingjie Wang, Yan Xu
Multiple Sclerosis and Related Disorders (2025) Vol. 96, pp. 106351-106351
Closed Access
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
Hesham Abboud, Andrea Salazar-Camelo, Naveen George, et al.
Journal of Neurology (2021) Vol. 269, Iss. 4, pp. 1786-1801
Open Access | Times Cited: 21
Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation
Wenjing Luo, Huiming Xu, Li Xu, et al.
Glia (2022) Vol. 71, Iss. 2, pp. 284-304
Closed Access | Times Cited: 15
Rodent Models of Optic Neuritis
Yael Redler, Michael Levy
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 20
Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
Emily J. Koller, Paramita Chakrabarty
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 19
Lack of astrocytes hinders parenchymal oligodendrocyte precursor cells from reaching a myelinating state in osmolyte-induced demyelination
Melanie Lohrberg, Anne Winkler, Jonas Franz, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 19
The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders
Panos Stathopoulos, Marinos C. Dalakas
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 9, pp. 933-945
Open Access | Times Cited: 11
The therapeutic effect of platelet-rich plasma on the experimental autoimmune encephalomyelitis mice
Maryam Borhani‐Haghighi, Yousef Mohamadi
Journal of Neuroimmunology (2019) Vol. 333, pp. 476958-476958
Closed Access | Times Cited: 17
The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders
Wenqun Li, Jiaqin Liu, Wei Tan, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 14, pp. 3059-3065
Open Access | Times Cited: 14
RETRACTED: TGN020 application against aquaporin 4 improved multiple sclerosis by inhibiting astrocytes, microglia, and NLRP3 inflammasome in a cuprizone mouse model
Yousef Mohamadi, Maryam Borhani‐Haghighi
Journal of Chemical Neuroanatomy (2023) Vol. 132, pp. 102306-102306
Closed Access | Times Cited: 5
Intranasal administration of conditioned medium derived from mesenchymal stem cells-differentiated oligodendrocytes ameliorates experimental autoimmune encephalomyelitis
Maryam Borhani‐Haghighi, Yousef Mohamadi
Journal of Chemical Neuroanatomy (2020) Vol. 106, pp. 101792-101792
Closed Access | Times Cited: 10
Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis
Leyre Mestre, Graciela Alonso, Ana Feliú, et al.
Aging Cell (2021) Vol. 20, Iss. 9
Open Access | Times Cited: 8
QKI-V5 is downregulated in CNS inflammatory demyelinating diseases
Iris Lavon, Ina leykin, Hanna Charbit, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 39, pp. 101881-101881
Closed Access | Times Cited: 8
Neuromyelitis optica spectrum disorder: an overview
Pooja Ramakrishnan, Devipriya Nagarajan
Acta Neurobiologiae Experimentalis (2020) Vol. 80, Iss. 3, pp. 256-272
Open Access | Times Cited: 4
Sera from Patients with NMOSD Reduce the Differentiation Capacity of Precursor Cells in the Central Nervous System
Ulises Gómez‐Pinedo, Yolanda García-Ávila, Lucia Gallego Villarejo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5192-5192
Open Access | Times Cited: 4
Aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress of experimental models based on disease pathogenesis
Li Xu, Huiming Xu, Changyong Tang
Neural Regeneration Research (2024) Vol. 20, Iss. 2, pp. 354-365
Open Access
Acetyl 11-Keto Beta-Boswellic Acid Improves Neurological Functions in a Mouse Model of Multiple Sclerosis
Saeed Karima, Seyyed Hossein Khatami, Sajad Ehtiati, et al.
Inflammation (2024)
Closed Access
OPTIC NEUROMYELITIS DEVICIS: IMMUNOPATHOGENESIS AND RISK FACTORS (literature review and clinical case)
E. R. Lutsiv, A. V. Budarna, Н. І. Ткачук, et al.
Medical Science of Ukraine (MSU) (2024) Vol. 20, Iss. 4, pp. 105-114
Open Access
Could Galectin-3 be a key player in the etiology of neuromyelitis optica spectrum disorder?
Pooja Ramakrishnan
Medical Hypotheses (2020) Vol. 146, pp. 110450-110450
Closed Access | Times Cited: 3
Overview of diet and autoimmune demyelinating optic neuritis: a narrative review
Scott M. Plafker, Tyler J. Titcomb, Katarzyna Zyla-Jackson, et al.
Immunometabolism (2023) Vol. 5, Iss. 2, pp. e00022-e00022
Open Access | Times Cited: 1
New ex vivo demyelination/remyelination models to defeat multiple sclerosis and neuromyelitis optica
Yiting Liu
Neural Regeneration Research (2019) Vol. 14, Iss. 10, pp. 1715-1715
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top